Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis

Background: Warfarin is effective for stroke prevention in atrial fibrillation (AF), but anticoagulation is underused in clinical care. The risk of venous thromboembolic disease during hospitalisation can be reduced by low-molecular-weight heparin (LMWH): warfarin is the most frequently prescribed a...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Jonathan AC Sterne, Pritesh N Bodalia, Peter A Bryden, Philippa A Davies, Jose A López-López, George N Okoli, Howard HZ Thom, Deborah M Caldwell, Sofia Dias, Diane Eaton, Julian PT Higgins, Will Hollingworth, Chris Salisbury, Jelena Savović, Reecha Sofat, Annya Stephens-Boal, Nicky J Welton, Aroon D Hingorani
Médium: Artigo
Jazyk:Inglês
Vydáno: NIHR Journals Library 2017-03-01
Edice:Health Technology Assessment
Témata:
atrial fibrillation
venous thromboembolic disease
anticoagulation
stroke
systematic review
meta-analysis
cost-effectiveness
On-line přístup:https://doi.org/10.3310/hta21090
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky